Evidence map›Paper›PMID 42521685›Full record

ArticleBlood cancer journal2026

Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study.

Lei Ju, Sifeng Gao, JiLei Zhang, Yuyu Liu, Qiang Song, Lin Dong, Yan Guo, Xuemei Qin, Jie Zou, Chenglu Yuan and 9 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Lei Ju *Department of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China.
Sifeng Gao *Department of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China.
JiLei ZhangDepartment of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China.
Yuyu LiuDepartment of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China.
Qiang SongDepartment of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Lin DongDepartment of Hematology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.
Yan GuoDepartment of Hematology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.
Xuemei QinDepartment of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Jie ZouDepartment of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Chenglu YuanDepartment of Hematology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, Shandong, China.
Yan ShiDepartment of Hematology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.
Dexiao KongDepartment of Hematology, The Qilu Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Kaifeng WangDepartment of Hematology, People's Hospital of Zhangqiu District, Jinan, Shandong, China.
Qiang LiDepartment of Hematology, Liaocheng People's Hospital, No. 67 Dongchang West Road, Liaocheng City, Shandong Province, China.
Donglin YangState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Qingliang TengDepartment of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China.
Erlie JiangState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China. jiangerlie@163.com.
Jun PengState Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, China. junpeng88@sina.com.
Guanchen BaiDepartment of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China. baiguanchen@qdu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42521685
PMCPMC13415782

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.